BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -20.09% | -47.69% | |||
| Gross Profit | 175.51% | 30.24% | |||
| SG&A Expenses | -36.64% | 41.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.78% | -21.74% | |||
| Operating Income | 102.58% | 4.83% | |||
| Income Before Tax | 107.12% | 35.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 107.12% | 35.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 107.12% | 35.16% | |||
| EBIT | 102.58% | 4.83% | |||
| EBITDA | 102.61% | 5.93% | |||
| EPS Basic | 106.44% | 48.36% | |||
| Normalized Basic EPS | 106.99% | 52.43% | |||
| EPS Diluted | 106.39% | 48.36% | |||
| Normalized Diluted EPS | 106.99% | 52.43% | |||
| Average Basic Shares Outstanding | 10.59% | 25.56% | |||
| Average Diluted Shares Outstanding | 10.66% | 25.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||